Access brought to you by: LOCKSS

Oncology Clinical Trials

Sentinel Lymph Node Biopsy before or after Neoadjuvant Chemotherapy: Final Results from the SENTINA Trial
Chemotherapy Prolongs Survival for Isolated Local or Regional Recurrence of Breast Cancer: The CALOR Trial
Profiling Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Targetable Genetic Alterations
The UK START Trials: 10-Year Follow-Up Results
HERA TRIAL: 2 Years versus 1 Year of Trastuzumab after Adjuvant Chemotherapy in Women with HER2-Positive Early Breast Cancer at 8 Years of Median Follow-Up
Effectiveness of Letrozole Compared with Tamoxifen for Patients with Lobular Carcinoma in the BIG 1–98 Trial
Neurocognitive Impact in Adjuvant Chemotherapy for Breast Cancer Linked to Fatigue: A Prospective Functional MRI Study
The Efficacy and Safety of Docetaxel Plus Prednisone with or without Lenalidomide in Patients with Castrate-Resistant Prostate Cancer: The MAINSAIL Trial
Two Years versus One Year of Trastuzumab in Patients with Early Breast Cancer
Adjuvant Trastuzumab for 6 versus 12 Months in Patients with Early Breast Cancer

Pages